Defective human T-cell lymphotropic virus type I (HTLV-I) provirus in seronegative tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM) patients
Infection with human T-cell lymphotropic virus type I (HTLV-I) have been associated with the development of the tropical
spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM). We studied the presence of HTLV-I provirus in peripheral blood
mononuclear cells (PBMC) from 72 Chilean patients with progressive spastic paraparesis by polymerase chain reaction: 32
seropositive and 40 seronegative cases. We amplified different genomic regions of HTLV-I using primers of 5' ltr, tax, env/tax, pX,
pol and env genes. These genes were detected from all seropositive patients. The seronegative patients were negative with 5' ltr, pol,
env , and pX primers. However, amplified product of tax and env/tax genes was detected from 16 and four seronegative patients,
respectively. Three of them were positive with both genetic regions. The results of this study show that the complete HTLV-I
provirus is found in 100% of seropositive cases. In seronegative cases, clinically very similar of seropositive cases, was found only tax
gene in 42.5% (17/40) of patients. These results suggest the presence of a defective HTLV-I provirus in some seronegative patients
with progressive spastic paraparesis, and suggest a pathogenic role of this truncate provirus for a group of TSP/HAM.
Defective human T-cell lymphotropic virus type I (HTLV-I) provirus in seronegative tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM) patients